Full-Time

Research/Senior Research Associate

Confirmed live in the last 24 hours

Voyager Therapeutics

Voyager Therapeutics

51-200 employees

Gene therapy and neurology advancement platform

Biotechnology

Senior

Lexington, MA, USA

Requirements
  • Bachelor/Masters degree in Biochemistry/Molecular/Cellular Biology or related discipline.
  • Minimum 1-5 years with MS, 2-5 years with BS of work experience in a research setting.
  • Hands-on experience with molecular techniques (ELISA, gel electrophoresis, western blotting, enzyme assays, qPCR, cloning).
  • Hands-on experience with cellular techniques (cell line passaging and maintenance, transfection, transduction).
  • Experience in developing and optimizing molecular biological and cell-based assays.
  • Outstanding problem solving and troubleshooting skills.
  • Ability to be highly productive and self-motivated in a fluid, fast-paced and team environment.
Responsibilities
  • Participate in Non-Viral therapeutics programs for BBB-penetrant protein biologics leveraging identification of new BBB transport modalities.
  • Execute in vitro and ex vivo assays to expand our capabilities in advancing our platform and proving our biology.
  • Collaborate with our novel capsid discovery team to accelerate advances in receptor ligand biology.
  • Conduct experimental procedures precisely and consistently by following established protocols, as well as document and maintain a well-organized account of lab work and results.
  • Regularly communicate results within the research organization and at conferences.

Voyager Therapeutics is an ideal workplace for those passionate about groundbreaking developments in gene therapy and neurology. The company's focus on its proprietary TRACER™ AAV capsid discovery platform allows for the creation of innovative treatments with enhanced delivery mechanisms, specifically targeting challenging diseases like Alzheimer's, ALS, and Parkinson’s. This commitment to technological advancement, coupled with significant collaborations with leading pharmaceutical companies, positions it as a leader in neuroscience research and development.

Company Stage

IPO

Total Funding

$344M

Headquarters

Cambridge, Massachusetts

Founded

2014

Growth & Insights
Headcount

6 month growth

8%

1 year growth

32%

2 year growth

47%